MDM2 and colorectal cancer: Subsequent in vitro demethylation of the ARF promoter in this colorectal cancer cell line demonstrated a translocation of MDM2 from the cytoplasm toward the nucleus, where it was subsequently inactivated by ARF, leading to P53 activation.